Welcome

🔬 Welcome to the Zunke Lab

We study the molecular mechanisms of neurodegeneration with a focus on Parkinson’s disease.

Research

Our Research

Lysosomal biology • Alpha-synuclein • Biomarkers • Astrocytes

Parkinson’s Disease

Advancing Parkinson’s Disease Research

Exploring disease mechanisms to better understand neurodegeneration and support future therapeutic strategies.

Brain Biology
About the Lab

Exploring cellular pathways in neurodegeneration

The Zunke Lab investigates how lysosomal function, protein aggregation, extracellular vesicles and glial cell biology contribute to neurodegenerative diseases such as Parkinson’s disease. Our goal is to uncover disease mechanisms and translate these findings into new diagnostic and therapeutic strategies.

Extracellular vesicles
01

What are EVs?

Extracellular vesicles are small particles released by cells that carry proteins, RNA and other molecular signals. We study how EVs can reflect disease-related changes and serve as potential biomarkers for Parkinson’s disease.

Cathepsin mechanisms
02

Mechanisms of cathepsins

Cathepsins are lysosomal proteases that help degrade and clear cellular proteins. We investigate how these enzymes influence α-synuclein turnover and whether enhancing lysosomal activity can reduce toxic protein aggregation.

Astrocytes and neuroinflammation
03

Glial cells & neuroinflammation

Astrocytes and other glial cells play key roles in brain homeostasis, inflammation and neuronal support. We explore how glial responses change during disease and whether they can become therapeutic targets.

Zunke Lab team
Our Team

Science is collaborative

Our interdisciplinary and international team combines expertise in cell biology, neuroscience, molecular medicine and translational research to better understand neurodegenerative disease mechanisms.

Network

Collaboration and Project Partners

Our research is strengthened through collaborations with clinical, scientific, and translational partners.

Collaboration and project partners